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OPINION
Reducing cardiovascular risk:
too little, too late, too short-
term
David Gray
University Hospital, Nottingham, UK
Vascular diseases in general, and cardiovascular disease in
particular, are diseases of mass destruction, killing more
people in the Western world (and increasingly in the
developing world) than world wars. Each year, coronary
heart disease kills over half a million Americans and over
100 000 British citizens each year, often prematurely
(WHO online).
A combination of migration, epidemiological, and
intervention studies confirm that lifestyle affects the onset
and progression of disease. Most of the excess risk of
coronary disease, at least in Western societies, is attributable
to well recognized major independent risk factors (cigarette
smoking, hypertension, elevated total and low-density
lipoprotein (LDL) cholesterol, low high-density lipoprotein
(HDL), diabetes mellitus, and advancing age).
Epidemiological studies have shown a continuum of risk
for increasing levels of blood pressure, total cholesterol,
LDL, and smoking (Wilson 1998). These are aggravated by
a variety of contributory predisposing factors (obesity and
abdominal obesity, physical inactivity, family history of
premature coronary disease, and ethnic characteristics),
psychosocial factors, and conditional risk factors (elevated
triglycerides, small LDL particles, prothrombotic factors
such as fibrinogen, insulin resistance, and abnormal levels
of lipoprotein(a) and homocysteine).
The UK heads most league tables for premature mortality
and morbidity from vascular disease. While crude statistics
adequately describe populations, illness affects individuals,
and the principal objective of preventive medicine is to
minimize the risk of avoidable vascular events in individuals
at varying degrees of susceptibility.
Measuring risk
Risk scoring systems have been developed from long-term
observational studies such as the Framingham (USA) study,
which followed first one and now two generations of middle
class white families (NHLBI online). Scoring systems
acknowledge the multifactorial causation of vascular
disease, sex differences in disease prevalence, and increased
risk due to the aging process. A variety of tables, charts,
and software packages are available, differing predominantly
in their usability and graphic presentation, but all provide
an estimate of global cardiovascular risk (and with some
calculators, stroke risk).
Risk calculators are designed for primary prevention
only – once vascular disease has become clinically apparent,
whether in cardiovascular, cerebrovascular, or peripheral
vessels, the likelihood of recurrent disease is very high.
Formal risk assessment is inappropriate, and all potentially
reversible risk factors must be addressed to minimize disease
progression.
Calculators provide an estimate of “absolute” risk, which
is the probability of developing disease over a finite time
period, usually ten years. Some scoring systems allow an
estimate of “relative” risk; that is, the ability to differentiate
individuals at “high” risk from those at some intermediate
or “low” risk.
Problems with risk calculators
Risk scoring systems are imperfect tools which have been
derived from a population comprising thousands of
individuals. Although scores indicate the potential extent
of risk, clinicians (and patients) must be aware that the future
outcome of a specific individual remains uncertain. The risk
estimate should be considered an “average” because
biological variability, inevitable in any population, can
generate a large spread of risk around the average. In
practical terms, this means that the estimate of risk for a
group will be correct, but the estimate for an individual could
be widely astray. It is entirely feasible that two people with
the same risk score may experience different outcomes.
The ease with which a risk score can be derived is not
matched by the certainty of outcome; the score provides no
more than a “best estimate” of an individual’s risk status
and fate. More than half of all coronary deaths and most
cases of myocardial infarction occur in those whose risk
prediction score would be considered to have a “low” or
“moderate” risk of a coronary event, reflecting the Gaussian
distribution of risk factor profiles in a given population.
Those involved in risk assessment need to be aware that a
person with a “low” risk may develop vascular disease while
someone at “high” risk may avoid it.
The databases from which the scoring systems were
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risk factors but did not take into account predisposing and
conditional risk factors. For example, evaluation of some
conditional risks such as LDL particles and serum
lipoproteins were not available to the Framingham monitors
(abnormal levels of these will increase the estimated risk).
The Framingham population were white and so an
adjustment needs to be made for individuals of other ethnic
backgrounds such as South Asians who have a 40% greater
risk of coronary disease. Consequently, in many cases, the
risk estimate should be considered to be minimum level of
risk.
It is tempting to assume (but there is no evidence to
support the concept) that reducing a risk factor by a given
amount will reduce overall risk to the same extent as an
increase in the same risk factor increases total risk. Even if
an individual’s lifestyle changes are rewarded with a marked
reduction in estimated risk, vascular risk is never zero and
so there can be no guarantee that an untoward vascular event
will not occur.
At the start of the Framingham study, few individuals
had diabetes mellitus. The prevalence of diabetes is high
and increasing in many populations, and this can have a
marked influence on absolute risk.
The greatest risk of all
Reducing reversible factors such as cholesterol and blood
pressure can reduce risk, but one factor dominates the risk
equation: with advancing age, risk inevitably increases. For
example, a non-smoking male aged 35–44 with a ratio of
total cholesterol to HDL of 6 and a systolic blood pressure
of 150 has over the next ten years a 15% risk of a coronary
event; at 45–64, bearing the same blood pressure and
cholesterol (though both may increase with age), his risk is
between 15% and 30%, and by the time he reaches 65, he
has a greater than 30% risk. This supports the concept that
risk factor management needs to be instituted early and
aggressively.
What is high risk?
The National Service Framework (NSF) for Coronary Heart
Disease defines “high risk” of developing coronary disease
in the subsequent ten years as greater than 30% (Department
of Health 2000). The proportion of the UK male population
with this degree of risk is about 3%. A further 16% have a
risk of 20% or more, and over half the adult male population
has a risk greater than 15%. For women, the overall risk is
less than half that of males.
If clinicians concentrate, as the NSF recommends, on
identifying and treating what Rose (1992, p 31) described
as “the deviant minority at high risk”, individuals may well
benefit, but there will be negligible impact on national
mortality and morbidity figures because intervention is being
offered to such a small proportion of the “at-risk” population.
Achieving a significant reduction in avoidable vascular
mortality and morbidity requires a shift in the population
mean risk.
Is the level of “high risk” set too high?
Although fewer coronary events occur in populations with
low levels of risk factors, coronary events occur at all levels
of risk – no level of risk can be considered “safe”.
Government may set the risk threshold for political
reasons and may also dictate to what extent the state is
prepared to protect the individual. Speed limits and central
crash barriers were introduced as knee-jerk reactions to
motorway accidents in poor visibility. In real terms, most
people in a lifetime of driving are at low risk of encountering
such an accident (unlike vascular disease), so the concept
of risk and risk reduction seems to be poorly understood.
The individual, however, must make a decision about
what degree of risk is personally acceptable and when (and
what) interventions are necessary.
Adoption of a 30% ten-year risk to trigger primary
prevention denies the majority of the UK population the
opportunity to prevent, or at least delay, a first vascular event.
Targeting those at high risk means that intervention is
delayed unnecessarily in those at more modest levels of risk,
exposing the vascular system to years of atherogenic
challenge from diabetes, hypertension, hyper-
cholesterolemia, and progressively increasing the burden
of plaque formation.
In this respect, it is illogical to delay intervention until
some arbitrary threshold of risk is reached. Even a modest
risk will, with time, reach levels which currently warrant
intervention, but long after atheromatous plaque has
developed throughout the arterial tree.
The risk factor burden of people in their twenties and
thirties needs to be reduced, as atherogenesis begins early
and is a lifelong hazard. For them, a ten-year perspective is
short term.
The population approach to risk
For years, clinicians were encouraged to treat a single risk
factor – hypertension. Addressing multiple risk factorsVascular Health and Risk Management 2005:1(1) 5
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increases the likelihood of benefit as the absolute risk is
higher, making intervention, including drug treatment, more
effective and more cost-effective.
When risk is common to many people, as is vascular
risk, a population-wide intervention strategy is more
appropriate. If a significant impact on premature mortality
and morbidity is to be achieved, it is essential to expand the
target population to include lower levels of risk. Because
long-term drug treatment can only be justified in high-risk
individuals, a population strategy must address lifestyle
changes to reduce risk.
In prevention terms, population strategies are more likely
to be successful than targeted policies. In reality, we are
practicing medical communism, whereby preventing an
adverse outcome requires many people to reduce their
individual risk – this is the “prevention paradox”. This
principle applies as much to common infectious disease (like
whooping cough or measles) and chronic degenerative
diseases (such as stroke and heart attack) as it does to public
health measures including legal enforcement of speed limits,
use of seatbelts, wearing of motorcycle helmets, and
fluoridation.
Which risk – relative or absolute?
Relative and absolute risk can be determined from several
risk calculators. Absolute risk lends itself to the identification
of individuals who should be advised on risk factor
reduction. Absolute risk, however, increases with age,
despite low cholesterol, low blood pressure, and a no-
smoking habit. This has two implications. First, an
increasing proportion of the population will reach the high-
risk threshold that currently warrants intervention (the 30%
risk). Second, more of those at modest risk will become
high risk. In both cases, applying the present 30% rule delays
intervention and permits years of overexposure to the
atherogenic process.
Relative risk, which decreases with age, can also inform
clinicians. Younger individuals with a high relative risk
(compared with their peers) face the additional challenge
of increased absolute risk with aging; they should be targeted
for long-term intervention to reduce risk. Older patients are
at high risk because of age; under present guidance, all will
be offered intervention, but those with a high relative risk
(compared with their peers) may be more worthy of
aggressive risk factor reduction in the short term.
The current high-risk strategy based on a high absolute
risk alone misses opportunities to intervene at an early stage
in risk, and atheroma, development.
Primary prevention: time for a reappraisal
Guidelines on levels of risk at which primary prevention
should be initiated are inappropriately high. A strategy that
targets only those with high risk ignores clinical evidence
that absolute risk increases with age, the overriding factor
in risk calculation. In practice, this means that, despite more
becoming appropriate for intervention with advancing age,
delayed intervention allows vascular plaque load to increase
unabated. A high-risk strategy applies to too few, too late to
have a major impact.
If primary prevention is to be effective, and to reduce
avoidable mortality and morbidity, a population strategy
should be introduced. Not only does the total risk factor
burden of the nation need to be addressed, which is a major
challenge for public health, but also younger patients with
excess relative risk should be considered for long-term
lifestyle intervention, with medication if essential. Finally,
the emphasis on a ten-year horizon instead of a ten-year
risk score, the perspective appropriate for younger
individuals, should be twenty years, or even longer.
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